Invert the vial and draw the dose: Flip the vial upside down Ensure the needle tip remains submerged in the liquid Pull back the plunger to draw your exact dose Tap to remove air bubbles and gently expel air if needed Switch needles: Remove the 23G drawing needle and attach the 25G 1" injection needle Step 4: Use the Air-Lock Technique To ensure no medication is lost in the needle hub: After drawing your dose, pull in an additional 0.2 mL of air Hold the syringe upright the air will sit at the top, behind the medication This air bubble acts as a piston to push all the testosterone out during injection Step 5: Administer the IM Injection With your non-dominant hand, hold the muscle firmly Insert the needle at a 90 angle in one quick, smooth motion Slowly depress the plunger to inject the full dose Remove the needle at the same angle Do not massage the injection site Dispose of the syringe and both needles in your sharps container After the Injection A small amount of soreness or redness at the site is normal Contact your provider if you experience swelling, persistent pain, or signs of infection Additional Tips Use a Sharpie to mark your usual dose on the syringe barrel for easy alignment Rotate injection sites each time to reduce the risk of irritation or tissue buildup Always confirm the dose before injecting Do not reuse needles or syringes Store your testosterone according to pharmacy instructions (usually at room temperature, away from light) Quick Summary Wash hands and clean the injection site Attach a 23G needle and draw in air equal to the dose Inject air into the vial, draw the testosterone dose Add 0.2 mL of air (air-lock technique) Switch to a 25G injection needle Hold the muscle, inject at a 90 angle Inject slowly, fully depress the plunger Remove needle, discard in sharps container
I have been using these products for a couple months and they are AMAZING
This causes rapid bone loss for about the first two years after starting Depo
We do not know whether the buccal absorption of methylcobalamin from an ODT is sufficient to fully compensate for the B12 absorption impairment caused by semaglutide
Per FDA guidance, GLP-1-based medications are generally approved for adults with a BMI over 30, or over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol
